Front-line medical workers are growing weary of COVID-19 denial and misinformation in treating unvaccinated patients during the delta-driven surge.
Health
Maine hospitals have fewer than 200 COVID patients for the first time in nearly 3 weeks
As of Monday, 192 people in Maine were in the hospital, including 61 in critical care.
California pushes first U.S. vaccine mandate for schoolchildren
Gov. Gavin Newsom says the requirement won’t take effect for all children until the U.S. government has finished fully vetting the COVID-19 vaccine for two age groups – 12 to 15 and 5 to 11.
Maine pharmacists flag ivermectin prescriptions from people seeking drug for COVID-19
The drug is intended to target infections caused by some parasitic worms in humans and animals, but many are seeking prescriptions because they believe it can ward off or treat COVID-19.
Maine author says father died after COVID-19 exposure in Bangor hospital
Christina Baker Kline says the virus was not the ultimate cause of her father’s death, but ‘he died in quarantine with COVID with multiple infections that he got in the hospital as the result of COVID-related delays.’
Health experts look to children as messengers to encourage more COVID-19 vaccinations
Dr. Nirav Shah, director of the Maine Center for Disease Control & Prevention, says informing youngsters of vaccine benefits could lead them to prod wary parents to get vaccinated.
MaineGeneral to honor cancer community with second annual Day of Hope
The Day of Hope combines two of the facility’s largest annual events — Cancer Survivors Day and the Walk for Hope — into one.
They were lauded as life-saving heroes. Now they’re being threatened.
Across the country, doctors and nurses on the front lines against the coronavirus are dealing with hostility, threats and violence from patients who are angry over safety rules.
FDA leans toward authorizing Moderna booster at a half dose
The authorization would set the stage to further widen the U.S. booster campaign after earlier authorization of the Pfizer shot.
Pfizer vaccine for children may be available in November
The drugmaker and its partner, Germany’s BioNTech, say they expect to request U.S. emergency use authorization of their vaccine in kids ages 5 to 11 ‘in the coming weeks.’